Product Information

POTASSIUM CITRATE ER 5 MEQ TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1336 per EA under NDC 68382053601. Its NADAC has been published 623 times since Sep 17, 2014.

FDA first approved this application on Aug 6, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CITRATE ER 5 MEQ TAB

Potassium Citrate
$0.1336per EA

Strength

5 meq/1

NDC

68382053601

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203546

FDA Approved

8/6/2014

TE Code

AB

On Market Since

8/12/2014

Pharmacological Classes

Acidifying Activity
Anti-coagulant
Calcium Chelating Activity
Calculi Dissolution Agent
Decreased Coagulation Factor Activity

Price Statistics

The NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has been published 623 times since Sep 17, 2014, and over the history we have for it it has declined 84.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1336 per EA
All-time high$0.9672 (Nov 15, 2017)
All-time low$0.1064 (May 22, 2024)
52-week high$0.1419
52-week low$0.1217
Median price$0.5962
Average price$0.5512
Largest weekly change+79.1% (Jan 18, 2023)
Weeks tracked623
Tracking sinceSep 17, 2014

Price History

1W

-5.9%

1M

-5.9%

3M

+3.6%

6M

+7.5%

1Y

+0.2%

3Y

-19.4%

5Y

-82.0%

All

-84.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CITRATE ER 5 MEQ TAB?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 5 MEQ TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1336 per EA (NDC 68382053601), effective Aug 19, 2026.

How has the price of POTASSIUM CITRATE ER 5 MEQ TAB changed over time?

Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has declined 84.9%. It has been tracked across 623 weekly CMS publications since Sep 17, 2014.

What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 5 MEQ TAB?

Since Sep 17, 2014, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has ranged from a low of $0.1064 (May 22, 2024) to a high of $0.9672 (Nov 15, 2017), with a median of $0.5962 per EA.

Are there cheaper alternatives to POTASSIUM CITRATE ER 5 MEQ TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CITRATE ER 5 MEQ TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CITRATE ER 5 MEQ TAB?

POTASSIUM CITRATE ER 5 MEQ TAB (NDC 68382053601) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.